Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Google Secures Pentagon AI Deal for Classified Projects
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 



